Table 1.
Activity of 3–29 (mono-substituted phenyl B-ring) against KB and KB-VIN
| R | ED50 (µM)a | Selectivity | |||||
|---|---|---|---|---|---|---|---|
| 2’ | 3’ | 4’ | 5’ | KB | KB-VIN | KB/KB-VIN | |
| 2 | >236.7 | 1.07 | >221 | ||||
| 3 | Me | 39.2 | 0.08 | 460 | |||
| 4 | Et | 21.9 | 0.07 | 320 | |||
| 5 | Pr | >53 | 12.16 | >4 | |||
| 6 | iPr | 8.13 | 1.08 | 3 | |||
| 7 | Bu | 110.7 | 36.95 | 3.0 | |||
| 8 | tBu | 29.3 | 17.4 | 2 | |||
| 9 | CF3 | 35.7 | 10.35 | 3.5 | |||
| 10 | OH | 20.6 | 20.6 | 1 | |||
| 11 | OMe | 17.7 | 0.68 | 26 | |||
| 12 | OEt | >52.4 | 7.54 | >7 | |||
| 13 | OPr | >50.5 | 29.17 | >2 | |||
| 14 | OCF3 | 36.49 | 9.95 | 4 | |||
| 15 | SMe | >52.1 | 1.38 | >38 | |||
| 16 | Br | >48.1 | 15.70 | 3 | |||
| 17 | F | 33.0 | 1.85 | 18 | |||
| 18 | CH2Br | >46.5 | 27.91 | >2 | |||
| 19 | CH2OMe | >52.4 | 3.40 | 15 | |||
| 20 | Me | 49.7 | 3.69 | 14 | |||
| 21 | CF3 | 35.7 | 5.42 | 6.6 | |||
| 22 | OMe | 13.3 | 1.22 | 11 | |||
| 23 | OCF3 | >47.4 | 9.95 | >5 | |||
| 24 | F | >56.2 | 3.09 | >18 | |||
| 25 | Me | 40.9 | 2.41 | 17 | |||
| 26 | CF3 | 45.6 | 43.10 | 1 | |||
| 27 | OMe | 40.8 | 3.26 | 13 | |||
| 28 | F | >56.2 | 3.93 | >14 | |||
Cytotoxicity as ED50 values for each cell line, the concentration of compound that caused 50% reduction in absorbance at 562 nm relative to untreated cells using the sulforhodamine B assay.